LATUDA is indicated for: Treatment of adult and adolescent patients (13 to 17 years) with schizophrenia.
Monotherapy treatment of adult and adolescent patients (13 to 17 years) with major depressive episode associated with bipolar I disorder (bipolar depression).
Adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder (bipolar depression).